BAYRY
Price
$7.21
Change
+$0.09 (+1.26%)
Updated
Jun 4 closing price
Capitalization
57.55B
62 days until earnings call
BIIB
Price
$131.86
Change
+$0.02 (+0.02%)
Updated
Jun 4 closing price
Capitalization
31.34B
48 days until earnings call
Interact to see
Advertisement

BAYRY vs BIIB

Header iconBAYRY vs BIIB Comparison
Open Charts BAYRY vs BIIBBanner chart's image
Bayer A.G
Price$7.21
Change+$0.09 (+1.26%)
Volume$453.47K
Capitalization57.55B
Biogen
Price$131.86
Change+$0.02 (+0.02%)
Volume$1.47M
Capitalization31.34B
BAYRY vs BIIB Comparison Chart
Loading...
BAYRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BIIB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BAYRY vs. BIIB commentary
Jun 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BAYRY is a Buy and BIIB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 05, 2025
Stock price -- (BAYRY: $7.21 vs. BIIB: $131.86)
Brand notoriety: BAYRY: Not notable vs. BIIB: Notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: BAYRY: 67% vs. BIIB: 81%
Market capitalization -- BAYRY: $57.55B vs. BIIB: $31.34B
BAYRY [@Pharmaceuticals: Major] is valued at $57.55B. BIIB’s [@Pharmaceuticals: Major] market capitalization is $31.34B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BAYRY’s FA Score shows that 0 FA rating(s) are green whileBIIB’s FA Score has 0 green FA rating(s).

  • BAYRY’s FA Score: 0 green, 5 red.
  • BIIB’s FA Score: 0 green, 5 red.
According to our system of comparison, BAYRY is a better buy in the long-term than BIIB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BAYRY’s TA Score shows that 7 TA indicator(s) are bullish while BIIB’s TA Score has 5 bullish TA indicator(s).

  • BAYRY’s TA Score: 7 bullish, 3 bearish.
  • BIIB’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, BAYRY is a better buy in the short-term than BIIB.

Price Growth

BAYRY (@Pharmaceuticals: Major) experienced а +3.15% price change this week, while BIIB (@Pharmaceuticals: Major) price change was +3.40% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +3.27%. For the same industry, the average monthly price growth was +2.61%, and the average quarterly price growth was +3.54%.

Reported Earning Dates

BAYRY is expected to report earnings on Aug 06, 2025.

BIIB is expected to report earnings on Jul 23, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+3.27% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BAYRY($57.5B) has a higher market cap than BIIB($31.3B). BIIB has higher P/E ratio than BAYRY: BIIB (26.95) vs BAYRY (17.04). BAYRY YTD gains are higher at: 48.450 vs. BIIB (-13.772). BAYRY has higher annual earnings (EBITDA): 12.1B vs. BIIB (2.04B). BAYRY has more cash in the bank: 7.98B vs. BIIB (1.05B). BAYRY has higher revenues than BIIB: BAYRY (50.5B) vs BIIB (9.84B).
BAYRYBIIBBAYRY / BIIB
Capitalization57.5B31.3B184%
EBITDA12.1B2.04B594%
Gain YTD48.450-13.772-352%
P/E Ratio17.0426.9563%
Revenue50.5B9.84B513%
Total Cash7.98B1.05B760%
Total DebtN/A7.34B-
FUNDAMENTALS RATINGS
BAYRY vs BIIB: Fundamental Ratings
BAYRY
BIIB
OUTLOOK RATING
1..100
1211
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
87
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10071
PRICE GROWTH RATING
1..100
4562
P/E GROWTH RATING
1..100
8796
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BAYRY's Valuation (67) in the null industry is in the same range as BIIB (87) in the Biotechnology industry. This means that BAYRY’s stock grew similarly to BIIB’s over the last 12 months.

BAYRY's Profit vs Risk Rating (100) in the null industry is in the same range as BIIB (100) in the Biotechnology industry. This means that BAYRY’s stock grew similarly to BIIB’s over the last 12 months.

BIIB's SMR Rating (71) in the Biotechnology industry is in the same range as BAYRY (100) in the null industry. This means that BIIB’s stock grew similarly to BAYRY’s over the last 12 months.

BAYRY's Price Growth Rating (45) in the null industry is in the same range as BIIB (62) in the Biotechnology industry. This means that BAYRY’s stock grew similarly to BIIB’s over the last 12 months.

BAYRY's P/E Growth Rating (87) in the null industry is in the same range as BIIB (96) in the Biotechnology industry. This means that BAYRY’s stock grew similarly to BIIB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BAYRYBIIB
RSI
ODDS (%)
Bearish Trend 1 day ago
77%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 1 day ago
73%
Momentum
ODDS (%)
Bullish Trend 1 day ago
54%
Bullish Trend 1 day ago
58%
MACD
ODDS (%)
Bullish Trend 1 day ago
57%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
55%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
55%
Advances
ODDS (%)
Bullish Trend 3 days ago
59%
Bullish Trend 1 day ago
54%
Declines
ODDS (%)
Bearish Trend 28 days ago
70%
Bearish Trend 13 days ago
70%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
49%
Bearish Trend 1 day ago
74%
Aroon
ODDS (%)
Bullish Trend 1 day ago
51%
Bullish Trend 1 day ago
35%
View a ticker or compare two or three
Interact to see
Advertisement
BAYRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BIIB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VSNGX63.60N/A
N/A
JPMorgan Mid Cap Equity I
MXLSX36.34N/A
N/A
Empower Small Cap Value Inv
DURCX13.70N/A
N/A
DWS ESG International Core Eq C
MELAX15.30N/A
N/A
Morgan Stanley Inst EMkts Ldrs A
UIWGX30.81N/A
N/A
Victory Sustainable World Institutional

BAYRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, BAYRY has been closely correlated with BAYZF. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if BAYRY jumps, then BAYZF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAYRY
1D Price
Change %
BAYRY100%
+1.26%
BAYZF - BAYRY
88%
Closely correlated
+2.21%
OPHLY - BAYRY
23%
Poorly correlated
N/A
SNY - BAYRY
23%
Poorly correlated
+0.63%
AZN - BAYRY
21%
Poorly correlated
+1.64%
BIIB - BAYRY
20%
Poorly correlated
+0.02%
More